睿昂基因: 睿昂基因关于2025年半年度利润分配方案的公告

Core Viewpoint - The company plans to distribute a cash dividend of 1.70 RMB per 10 shares (including tax) for the first half of 2025, without any capital reserve transfer or bonus shares [1][2]. Profit Distribution Plan - As of June 30, 2025, the company's undistributed profits amount to approximately 140.34 million RMB in the consolidated financial statements and 13.32 million RMB in the parent company financial statements [1]. - The total share capital is 55,855,896 shares, and after deducting 669,621 shares in the repurchase account, the shares eligible for distribution are 55,186,275 [2]. - The total cash dividend to be distributed is approximately 9.38 million RMB (including tax), which represents 263.95% of the net profit attributable to the parent company for the first half of 2025 [2]. Legality and Compliance of the Distribution Plan - The distribution plan complies with relevant regulations and company articles, ensuring that it considers shareholder returns and future funding needs [3]. - The company has sufficient cash and financial assets, totaling approximately 213 million RMB, to support the cash dividend and future operations [4]. Decision-Making Process - The board of directors approved the profit distribution plan with unanimous consent during the meeting held on August 27, 2025, and it will be submitted for approval at the second extraordinary general meeting of shareholders in 2025 [4]. - The supervisory board also approved the plan, confirming that the preparation and review processes comply with legal and regulatory requirements [4].